Table 2.
Comparisons of types of liver disease.
| All patients | Troponin | |||
|---|---|---|---|---|
| Negative | Intermediate | Elevated | ||
| Primary liver disease (n) | 78 | 42 | 28 | 8 |
| Alcohol | 10 (12.8%) | 5 (11.9%) | 2 (7.1%) | 3 (37.5%) |
| Hepatitis C | 30 (38.5%) | 19 (45.2%) | 9 (32.1%) | 2 (25.0%) |
| NASH | 11 (14.1%) | 5 (11.9%) | 4 (14.3%) | 2 (25.0%) |
| PBC | 5 (6.4%) | 2 (4.8%) | 3 (10.7%) | 0 (0.0%) |
| PSC | 5 (6.4%) | 4 (9.5%) | 1 (3.6%) | 0 (0.0%) |
| Acetaminophen | 1 (1.3%) | 1 (2.4%) | 0 (0.0%) | 0 (0.0%) |
| Cryptogenic | 13 (3.9%) | 6 (14.3%) | 6 (21.4%) | 1 (12.5%) |
| Polycystic | 2 (2.6%) | 0 (0.0%) | 2 (7.1%) | 0 (0.0%) |
| Autoimmune | 1 (1.3%) | 0 (0.0%) | 1 (3.6%) | 0 (0.0%) |
| Secondary liver disease (n) | 19 (24.4%) | 13 (31.0%) | 5 (17.9%) | 1 (12.5%) |
| Alcohol | 3 (15.8%) | 2 (15.4%) | 1 (20.0%) | 0 (0.0%) |
| Hepatitis C | 1 (5.3%) | 0 (0.0%) | 1 (20.0%) | 0 (0.0%) |
| HC | 15 (78.9%) | 11 (8.5%) | 3 (60.0%) | 1 (100.0%) |
NASH: nonalcoholic steatohepatitis; PBC: primary biliary cirrhosis; PSC: primary sclerosing cholangitis; acetaminophen: acetaminophen toxicity; HC: hepatocellular carcinoma.